In isolation, yes. We don't really know how many group(s) are shorting, and how long they have been adding to their positions to estimate what their actual average sell price is. If we work on the assumption that the same group(s) have been shorting this stock since the Culper report, my estimate is that they would need to cover out their positions below $16 to return a profit.
In the middle of November, the stock nearly reached $17 before it got slammed back down. My estimate for the rolling short average was around that figure at that time. There's no scientific method to this due to the lack of data, I was using VWAP and the net change to get an idea of this figure (per day) and then averaging it all out.
I also really don't know what the overall impact shorting is to the overall picture. I think it is mainly the poor sentiment and momentum affecting things and shorts just capitalise on that.
- Forums
- ASX - By Stock
- Share Price
NEU
neuren pharmaceuticals limited
Add to My Watchlist
3.61%
!
$17.23

In isolation, yes. We don't really know how many group(s) are...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.23 |
Change
0.600(3.61%) |
Mkt cap ! $2.167B |
Open | High | Low | Value | Volume |
$16.80 | $17.34 | $16.63 | $4.229M | 248.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 575 | $17.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.24 | 69 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 45 | 17.210 |
7 | 211 | 17.200 |
10 | 512 | 17.190 |
7 | 902 | 17.180 |
8 | 1033 | 17.170 |
Price($) | Vol. | No. |
---|---|---|
17.230 | 30 | 1 |
17.240 | 781 | 7 |
17.250 | 1563 | 7 |
17.260 | 944 | 6 |
17.270 | 959 | 6 |
Last trade - 13.21pm 31/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |